NFG
CRL icon

Next Financial Group’s Charles River Laboratories CRL Stock Holding History

Next Financial Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$745K Buy
1,977
+717
+57% +$279K 0.05% 396
2021
Q3 		$520K Buy
1,260
+108
+9% +$44.9K 0.04% 450
2021
Q2 		$426K Buy
1,152
+13
+1% +$4.34K 0.03% 535
2021
Q1 		$330K Buy
1,139
+47
+4% +$13.1K 0.03% 579
2020
Q4 		$273K Sell
1,092
-3
-0.3% -$714 0.03% 597
2020
Q3 		$248K Sell
1,095
-198
-15% -$41.1K 0.03% 550
2020
Q2 		$225K Sell
1,293
-194
-13% -$31K 0.03% 496
2020
Q1 		$188K Sell
1,487
-224
-13% -$33.6K 0.02% 559
2019
Q4 		$261K Sell
1,711
-40
-2% -$5.54K 0.03% 597
2019
Q3 		$232K Sell
1,751
-268
-13% -$35.9K 0.03% 609
2019
Q2 		$286K Buy
2,019
+90
+5% +$12.2K 0.03% 538
2019
Q1 		$280K Buy
+1,929
New +$253K 0.07% 278

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Next Financial Group's CRL Position: Q4 2021 in Review

Next Financial Group increased its Charles River Laboratories (CRL) stake by 57% in Q4 2021, buying an estimated $279K and bringing the position to 1,977 shares worth $745K. The position accounts for 0.05% of the portfolio, ranked #396.

Next Financial Group first reported a position in CRL in Q1 2019 and has held it in 12 quarters since. 707 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

  • Next Financial Group held 1,977 shares of Charles River Laboratories worth $745K as of Q4 2021.
  • Next Financial Group bought 717 Charles River Laboratories shares in Q4 2021, an estimated $279K.
  • Charles River Laboratories made up 0.05% of Next Financial Group's portfolio in Q4 2021, its #396 holding.
  • Next Financial Group first reported a position in Charles River Laboratories in Q1 2019 and has held it in 12 quarters since.
  • 707 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.